At our EHN Guardians Gateway facility, we use pharmacogenetics assessment to help inform medication decisions that support long-term addiction and mental health recovery. Here’s what it is and why it works.
For many people seeking help for mental health challenges, trauma, or addiction, starting or even making medication changes can feel uncertain. Will it work? Will there be side effects? How long will it take to feel better?
Finding the right medications has often involved adjusting doses, switching medications, and waiting weeks or months to see results. However, a scientific approach known as pharmacogenetics is changing that. Pharmacogenetics is helping clinicians move toward personalized, precision-based care.
What is pharmacogenetics?
Pharmacogenetics is the study of how your genes influence the way your body responds to medications.[pmc.ncbi.nlm.nih.gov] It’s part of a broader shift toward precision psychiatry and personalized medicine in mental health care.
Pharmacogenetics focuses on genetic variations, particularly those that affect how medications are metabolize, to better predict:
- Which medications may work best for you
- Which may be less effective
- Which could increase the risk of side effects
Because each person processes medication differently at a biological level, pharmacogenetics allows care teams to tailor treatment based on the individual, not the average patient. [emeded.org]
Pharmacogenetics is changing mental health and addiction treatment for the better.
In mental health and addiction care, medication can be life-changing, but finding the right one isn’t always straightforward. People can respond very differently to the same medication due to genetic differences, often leading to:
- Delayed symptom relief
- Frustration and disengagement
- Increased side effects
- Longer recovery timelines
Pharmacogenetic testing helps address this by providing clinically relevant insights early in treatment, allowing for more informed decisions. [disability…gement.com]Instead of relying solely on trial and error, care teams can:
- Identify more suitable medications sooner
- Adjust dosing with greater precision
- Reduce the risk of ineffective treatments
- Minimize avoidable side effects
A shift to precision care
Prescribing psychiatric medication has been compared to “finding a needle in a haystack”—a process that can take months to get right. [questdiagnostics.com] Pharmacogenetic-guided care helps remove much of that uncertainty by predicting how an individual’s body will respond to medications.
Research suggests this approach can improve treatment response and remission rates, reduce adverse drug reactions, and shorten the time it takes to find an effective medication [frontiersin.org] For clients, this can mean faster stabilization, fewer setbacks, and greater confidence in their treatment plan.
How pharmacogenetics supports recovery
Recovery is about reducing symptoms, while regaining stability, clarity, and confidence. By supporting better-informed medication decisions, pharmacogenetics can:
- Accelerate recovery timelines
- Improve daily functioning
- Enhance engagement in therapy and programming
- Support long-term outcomes and relapse prevention
When individuals feel better sooner—and experience fewer side effects—they are more likely to stay engaged in their care and build momentum in recovery.
Personalized care at EHN Guardians Gateway
At EHN Guardians Gateway in Peterborough, Ontario, we are committed to combining compassionate care with the latest clinical innovations. Our programs are designed specifically for military members, veterans, and first responders, offering evidence-based treatment for trauma, PTSD, and substance use disorders.
As part of this commitment to clinical excellence, pharmacogenetic assessment supports:
- More precise medication matching for PTSD, trauma, and addiction treatment
- Individualized treatment planning based on each client’s biology
- Enhanced clinical decision-making and continuity of care
This reflects our core philosophy: no two recovery journeys are the same, and treatment shouldn’t be either. Pharmacogenetic assessment is one of the assessment services we offer to help inform an individualized treatment plan, where clinically appropriate. Availability may depend on each client’s coverage—such as Veterans Affairs Canada, WSIB, or another provider—or can be arranged on a self-funded basis.
Here’s what our patients have to say
For many clients, pharmacogenetic testing marks a turning point—when treatment feels truly aligned.
“After trying different medications with limited success and significant side effects, genetic testing finally provided answers. It helped identify how my body metabolizes medications and guided better treatment decisions. If it wasn’t for this testing and finding a medication that truly works for me, I would still be stuck in that cycle—feeling physically unwell on top of everything else.”
—EHN Guardians Gateway Alum
“After years of medication changes, dosage adjustments, and difficult side effects, choosing pharmacogenetic testing was an easy decision. The results were incredibly detailed and helped me move away from the trial-and-error approach. During my time at Gateway, I started feeling better sooner, which allowed me to focus on my recovery—not just managing side effects. Even after discharge, the results continue to guide my care and support better decisions with my psychiatrist.”
—EHN Guardians Gateway Alum
Part of the move toward precision psychiatry in Canada
Pharmacogenetics is part of a growing movement toward precision psychiatry in Canada, where treatment is more targeted, more efficient, and more effective. At EHN Guardians, we are proud to offer pharmacogenetic-informed care as part of this movement, combining clinical expertise, innovation, and compassionate care to deliver better outcomes for the people we serve.